How to stand out for Nouscom
Talent Graph
Apply with your Role Readiness, not just a resume.
Role Readiness is a 0-100 score for your target role, built only from proof - certifications, cleared simulations, ranked projects. It shows a recruiter what you can actually do, in one link, before any interview.
About Nouscom
Nouscom is a clinical-stage biotech company redefining cancer immunotherapy through its proprietary viral vector platform. Headquartered in Basel, Switzerland, Nouscom develops both off-the-shelf and personalized neoantigen immunotherapies that activate robust and durable T cell responses in cancer patients. Our lead program, NOUS-209, is advancing toward registrational for cancer interception in Lynch Syndrome carriers, a transformative opportunity for these patients.
The program has received positive regulatory feedback with a global registrational trial expected to launch in H1 2026. Nouscom’s second clinical program, NOUS-PEV, is a personalized immunotherapy for advanced solid tumors. It has demonstrated clinical responses in metastatic melanoma patients and is supported by a fully automated GMP manufacturing process that enables scalable delivery within 8 weeks.
Nouscom is supported by leading life sciences investors including 5AM Ventures, Andera Partners, M Ventures, Bpifrance, EQT Life Sciences, Indacos, Panakes, Revelation, Versant Ventures and XGen Ventures. Our platform is clinically validated in over 170 patients and offers unmatched immunogenicity, scalability, and safety — positioning Nouscom as a frontrunner in the next generation of cancer immunotherapy.
🔗 Learn more at http://www.nouscom.com
Open roles
0 listed · tech, AI & dataNo open tech roles right now.
We're still locating their careers page.
Talent snapshot
Employee functions
Employee locations
Common skills